Dendritic cells (DCs) are special subsets of antigen-presenting cells chara
cterized by their highly potent capacity to activate immunologically naive
T cells. Here we report that DCs that are transfected with CD95 ligand (CD9
5L) cDNA, called 'killer' DCs, deliver death signals, instead of activation
signals, to T cells after antigen-specific interaction. Injection of antig
en-pulsed killer DCs into mice before sensitization induced antigen-specifi
c immunosuppression. When administered after sensitization, killer DCs supp
ressed immune responses almost completely after subsequent challenge. Thus,
killer DCs represent an entirely new immunomodulatory protocol, which may
become directly applicable in preventing and even treating T cell-mediated
inflammatory diseases.